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The c-Jun N-terminal kinase (JNK) is part of a stress signalling pathway strongly activated by NMDA-stimulation and involved
in synaptic plasticity. Many studies have been focused on the post-synaptic mechanism of JNK action, and less is known about
JNK presynaptic localization and its physiological role at this site. Here we examined whether JNK is present at the presynaptic
site and its activity after presynaptic NMDA receptors stimulation. By using N-SIM Structured Super Resolution Microscopy as
well as biochemical approaches, we demonstrated that presynaptic fractions contained significant amount of JNK protein and its
activated form. By means of modelling design, we found that JNK, via the JBD domain, acts as a physiological effector on T-
SNARE proteins; then using biochemical approaches we demonstrated the interaction between Syntaxin-1-JNK, Syntaxin-2-JNK,
and Snap25-JNK. In addition, taking advance of the specific JNK inhibitor peptide, D-JNKI1, we defined JNK action on the SNARE
complex formation. Finally, electrophysiological recordings confirmed the role of JNK in the presynaptic modulation of vesicle
release. These data suggest that JNK-dependent phosphorylation of T-SNARE proteins may have an important functional role in
synaptic plasticity.
1. Introduction
The c-Jun NH2-terminal protein kinase (JNKs) is part of the
mitogen-activated protein kinase (MAPK) family [1, 2] and
is represented in mammals by three genes coding for three
isoforms: JNK1, JNK2, and JNK3. JNK1 and JNK2 expression
is essentially ubiquitous, while JNK3 presence is restricted to
brain and testis [3]. JNKs activation is led by several types of
extracellular stress stimuli such as heat shock, UV irradiation,
inflammatory cytokines, A𝛽 oligomers-induced toxicity, and
excitotoxicity, primarily leading to cell death.
JNK phosphorylates numerous important substrates,
including transcription factors AP-1, c-Jun, and Fos, leading
to activation of nuclear response [3–5]. Furthermore, JNK
regulates intracellular signalling pathways phosphorylating
many cytosolic and cell-membrane targets. Many data
pointed out that the JNK activation in the brain is higher than
in any other mammalian tissue [6–8], suggesting that kinase
might play an important role in the central nervous system
(CNS), regulating both physiological and pathological brain
processes.
JNK activation, in fact, induces neuronal death in a wide
range of pathological conditions, such as NMDA-induced
excitotoxicity, ischemic stroke [9–11], and traumatic brain
injury [12]; JNK activation has been also associated to many
neurodegenerative disorders like Alzheimer [13–18], Hunt-
ington’s [19], and Parkinson’s disease [20, 21], but also psychi-
atric disorders and intellectual disabilities involving synaptic
structure anomalies [22]. On the other hand, JNK plays
also an important role in regulating physiological processes
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such as neuronal precursors migration, axonal sprouting
and polarization, dendritic branches elongation, dendritic
spines stabilization, and therefore neuronal plasticity and
regeneration in the adult brain.
All these evidences point out that JNK pathway in the
CNS is particularly intricate, since it is not only subjected
to different types of stimulations, which modulate JNK
response, but it also plays different roles depending on its
localization, having JNK pool distinct functions in the var-
ious cellular districts. Since neurons are exquisitely polarized
cells, it is plausible that JNK activation may have different
roles and functions in diverse subcellular localizations, from
nuclear to cytoplasmic compartments as well as axons,
dendrites, and dendritic spines. This effect is not only due
to compartmentalization, but also due to the huge variety of
JNK’s targets. For instance c-Jun, the JNK elective target, is
localized in the nucleus and regulates gene expression, while
microtubule associated proteins (MAPs) are in the cytoplasm
[23–26] and control axon elongation and dendrite branching
[22]. More recently, JNK has been also identified at synaptic
sites [27–29]; however its role in this district as well as its
activation level is not completely clear yet.
Different works suggested that JNK is preferentially
located in postsynaptic regions, where it interacts with
key synaptic scaffold proteins (PSD-95 and PSD-93) as
well as with GluR2 AMPAR subunit (GluR2L) [30]. We
demonstrated that JNK has an important role in regulat-
ing glutamate receptors expression at postsynaptic density
level after A𝛽-induced toxicity in hippocampal neurons [17,
31]. Furthermore, many lines of evidence demonstrated the
importance of NMDA receptors (NMDARs) as JNK acti-
vators in the postsynaptic compartment [9, 32], suggesting
that JNK might have a crucial role in synaptic plasticity as
well as in excitotoxicity. NMDA-induced excitotoxicity in
fact, mediated mainly by postsynaptic NMDARs, powerfully
activates JNK, and JNK specific inhibition preventsNMDAR-
mediated neuronal death in cortical neurons [9, 10, 25] as
well as in organotypic hippocampal slices culture [9]. How-
ever, less is known about the biological role of presynaptic
NMDARs (pre-NMDARs) and their downstream pathways.
The pre-NMDARs have been extensively characterized in
the last years as new key-players during development and
memory consolidation phases. They are mainly involved in
synaptic strength modulation, through mechanisms rang-
ing from spontaneous neurotransmitter release facilitation
to LTP/LTD [33–39]. The pre-NMDARs are abundantly
expressed in the developing nervous system [40–42] although
their expression decreases in the adult, persisting only in
most plastic brain areas (such as neocortex, cerebellum, and
hippocampus) [43]. Importantly, their aberrant activation
has been also associated to pathological events [44, 45].
Although JNKs presence in postsynaptic compartment has
been characterized, there is lack of data for their presence
and physiological role at presynaptic sites.Herewe investigate
JNK localization and role in presynaptic compartment. JNK
identification at the presynaptic site and its activation after
NMDARs stimulation may be important not only to clarify
this issue, but also for the identification of new targets con-
tributing to synaptic plasticity. Moreover, JNK downstream
pathway definition could represent a new therapeutic tool to
prevent synaptic dysfunction in neurodegenerative diseases.
2. Materials and Methods
2.1. Purified Synaptosomes Extraction. Purified synapto-
somes from mice cortex were extracted as in Dunk-
ley [38]. Briefly, tissues were gently homogenated with a
glass-Teflon grinder in ST buffer (sucrose 320mM, Tris
10mM; pH 7.4) supplemented with protease and phos-
phatase inhibitors. Homogenates were centrifuged (1.000𝑔
5min 4∘C) and supernatants were collected and centrifuged
again (13.000 rpm, 20min, 4∘C). Pellet was resuspended
in ST buffer and stratified on a 20–10–6–2% Percoll (GE
Healthcare) gradient in ST buffer, prepared in ultracentrifuge
tubes. Samples were then ultracentrifuged, for 8min 33500𝑔
4∘C and interface between 10% and 20% layers, containing
purified synaptosomes, was aspired. Purified synaptosomes
were then precipitated 20min 10.000𝑔 4∘C in 6 : 1 vol/vol
Hepes Buffer (NaCl 140mM, KCl 3mM, MgSO4 1.2mM,
CaCl2 1.2mM, NaH2PO4 1mM, NaHCO3 3.5mM, glucose
10mM, Hepes 5mM; pH 7.4, Sigma). Pellet was lysed or
resuspended in the appropriate buffer.
2.2. Crude Synaptosomes Extraction. Crude synaptosomes
were used for calcium currents evaluation. Brains were
homogenated with a glass-Teflon grinder in SHE buffer
(Hepes 4mM pH 7.3, sucrose 320mM, EGTA 1mM, Sigma)
with protease inhibitors and phosphatase inhibitors. After
a first centrifuge (10.000𝑔 10min 4∘C), supernatant was
collected and again centrifuged (12.500𝑔, 20min 4∘C). Pellet
was resuspended in SHE buffer and subjected to a third
centrifuge (12.500𝑔, 20min, 4∘C) in order to obtain crude
synaptosomal fraction pellet, which was resuspended in
KRH buffer (NaCl 125 mM, KCl 5mM, MgSO4 1.2mM,
KH2PO4 1.2mM,HepesNaOHpH7.4 25mM, glucose 6mM,
CaCl2 2mM, Sigma) and kept at 37
∘C 5% CO2 for 45min,
for functional reactivation. Crude reactivated synaptosomes
were then resuspended at a final concentration of 1mg–
500 𝜇g/ml in KRH. After resuspension, synaptosomes were
kept at 37∘C 5% CO2 for 25min for an habituation step.
2.3. Calcium Currents Evaluation. Calcium currents were
measured on crude synaptosomes. Briefly, after reactivation
step, synaptosomes were pelleted as described before, resus-
pended in 300 𝜇l 1 : 1 mixture using KRH and calcium sen-
sitive cell-permeating fluorophore Fluo-4 (Fluo-4 Direct
Calcium Assay, Life Technologies). Samples were placed
in a whole black 96-well (Corning Costar 96-Well Black
Polystyrene Plate) for 25min 37∘C 5%CO2 to allow Fluo-4 to
permeate cell membranes. After habituation fluorescence was
measuredwith aTecan F500 spectrophotometer for 180 cycles
(corresponding to approximately 7 minutes) at 37∘C. NMDA
(100 𝜇M, with glycine coagonist 1𝜇M final concentration) or
KCl (50mM final concentration) were injected 100𝜇l/sec at
cycle 20 (45 sec). Fluorescence was recorded by a top mode
reading optimizing Z-position.
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2.4. Synaptosomes Stimulation. 25 minutes before stimula-
tion D-JNKI1 peptide (Xigen) is added to the medium at
a final concentration of 2 𝜇M. Synaptosomes were treated
with NMDA 100𝜇M (Abcam) with glycine coagonist 1𝜇M
(Sigma) or KCl 50mM (Sigma) for 2󸀠, 5󸀠, 7󸀠, or 10󸀠 at 37∘C
5% CO2. For NMDA stimulation MgSO4 was omitted from
the buffer. At the end of the stimulation synaptosomes were
resuspended in lysis buffer. For western blotting analysis
Bonny lysis buffer was used [25] while for SNARE complex
evaluation SNARE buffer was used [37].
2.5. Immunoprecipitation. Immunoprecipitation was con-
ducted on purified cortical synaptosomes as previously
described [39]. Immunoprecipitation antibodies, all used
at 1 : 100, were anti-JNK (#06-748, Upstate), anti-Syntaxin-1
(#A1238, Assay Biotech), anti-Syntaxin-2 (#110 022, Synaptic
Systems), and anti-Snap25 (#331, Chemicon). After precipita-
tion process 0.5–1 𝜇g proteins were subjected to SDS-Page.
2.6. SDS-PAGE. 20𝜇g of brain homogenates, TIF (Triton-
Insoluble Fraction), extracted as in [40] crude/purified
synaptosomal proteins, was separated by SDS (Bio-Rad)
polyacrylamide gel electrophoresis (ProtoGel, National Diag-
nostics). For SNARE complex detection, samples (referred to
as unboiled) were kept at RT for 7min before loading. Anti-
bodies usedwere anti-p-JNK and-JNK (#9251 and #9252 both
Cell Signalling, 1 : 1000), anti-Syntaxin-1 (#78539, Abcam),
anti-Syntaxin-2 (#S0664, Sigma, 1 : 5000), Snap25 (Stressgen,
1 : 5000), anti-Syntaxin-1 (Abcam, 1 : 5000), anti-Vamp (#104
211, Synaptic Systems), anti-Synaptophysin (#S5768, Sigma),
anti-PSD95 (#10011435, Cayman Chemicals, 1 : 1000), and
anti-Actin (1501, Millipore, 1 : 5000). Blots were developed
using ECL chemiluminescence system (ECL Western Blot-
ting Substrate, Promega) and quantified by densitometry
using ImageJ software.
2.7. Immunofluorescence. After extraction, purified synapto-
somes were processed as in Sokolow [41]. Primary antibodies
used were anti-Synaptophysin 1 : 500 (#S5768, Sigma) and
anti-p-JNK 1 : 100 (#6254, Santa Cruz) while fluoresceinated
secondary antibodies were Alexa Fluor 488 anti-Mouse
and Alexa Fluor 594 anti-Rabbit antibodies. Images were
acquired with Super-Resolution microscope (N-SIM, Nikon-
Structured Illumination Microscopy). Protein colocalization
was analysed using Pearson’s colocalization coefficient with
Imaris software.
2.8. Acute Slice Preparation. Experiments were performed
on horizontal slices prepared from the somatosensory cortex
of CD-1 mice of either sex, 2-3-month-old. Each animal
was anaesthetized with isoflurane, USP (Abbott Laboratories,
Illinois, USA), and decapitated.Thewhole brainwas removed
and rapidly immersed in ice-cold extracellular saline solution
containing (mM): Tris-Hcl 72, Tris-Base 18, NaH2PO4 1.2,
NaHCO3 30, KCl 2.5, Glucose 25, HEPES 20, MgSO4 10, Na-
PIR 3, ascorbic acid 5, CaCl2 0.5, sucrose 20, pH 7.4. Horizon-
tal somatosensory slices (200𝜇m thickness) were obtained
using a vibratome (Vibroslice 752, Campden Instruments,
Loughborough, UK). The slices were placed in a solution
containing (mM): 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2,
1.25 NaH2PO4, 26 NaHCO, 20 glucose, and the pH was
maintained at 7.4 for 25/30min a 32∘C and then maintained
at room temperature.
2.9. Electrophysiology. After a recovery period of at least 1 h,
an individual slice was transferred to a recording cham-
ber and continuously perfused with extracellular solution
at room temperature (22/25∘C). Whole-cell voltage-clamp
recordings were made from cortical neurons using an EPC-8
patch-clamp amplifier (HEKA Elektronik, Lambrecht/Pfalz,
Germany). Pipettes of borosilicate glass, with a tip resistance
between 2.0 and 3MΩ, were used for patch-clamp recordings
[42].The intracellular solution had the following composition
(mM): K-gluconate 117, KCL 13, MgCl2⋅6H20 2, Hepes 10,
CaCl2 1, EGTA 11, Na2ATP 2, Na3GTP 0.5, pH 7.3. Voltage-
clamp recordings were accepted only if the series resistance
was less than 10MΩ. Data were filtered at 3 kHz and digitized
at 10 kHz using the filter and analog/digital converter of the
amplifier. Digitized data were stored on computer disk using
the Pulse software (HEKA Elektronik).
2.10. Statistical Analysis. At least three independent replicates
have been performed for each experiment. Statistical analysis
was done using Graph Pad Prism 6 program. Data were
analysed using Student’s t-test and one- or two-way ANOVA,
followed by Dunnet/Tukey’s post hoc test. All data were
shown as mean ± SEM with statistical significance given at
𝑝 < 0.05.
2.11. Computational Analysis. The pairwise alignment be-
tween Syntaxin-1 (Uniprot ID Q16623) and Syntaxin-2
(Uniprot ID P32856) was performed using Needle software
available in the European Molecular Biology Open Software
Suit (EMBOSS) (PMID: 10827456).
The structure of Syntaxin-1 for the docking simulations
with JNK1 was extracted from the Syntaxin-1-Munc18A
complex (10.1038/emboj.2008.37). The structure of JNK1
complexed with a small peptide belonging to JIP scaffold
protein [43] was selected for the docking simulations. The
structure of Snap25was extracted from the 20S supercomplex
[44] while the same JNK1 structure selected for the docking
with Syntaxin-1 was also used. The docking simulation was
performed using HADDOCK 2.2 [45] program that is one of
the most suitable software to correctly predict the protein-
protein complexes. The images have been obtained using the
software UCSF Chimera v.1.10.1.
3. Results
3.1. JNK Is Located in the Presynaptic Compartment. To
investigate JNK localization in presynaptic compartment, we
used N-SIM Structured Super Resolution Microscopy on
isolated cortical synaptosomes (Figure 1(a)). Synaptosomes
were double stained for Synaptophysin, a constitutive and
specific presynaptic protein (labeled in red) and for the JNK
active form p-JNK (labeled in green, Figure 1(a)). As shown
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Figure 1: JNK is localized in the presynaptic compartment. (a) Immunofluorescence on mouse cortical purified synaptosomes stained for p-
JNK (green) and for Syntaxin-2 (red) colocalization is visualized as yellow signal inMerge image, with Pearson’s coefficient 0.54± 0.08. Images
acquired with super resolution microscopy; scale bar 1 𝜇m. (b) Western blotting analysis of JNK and p-JNK active form presence in 20 𝜇g
of total cortical lysates, postsynaptic density region (represented by PSD95 postsynaptic specific protein on TIF fraction) and presynaptic
compartment (represented by Synaptophysin presynaptic specific protein on purified synaptosomes). JNK is localized both in postsynaptic
and in presynaptic region and its phosphorylation state is comparable. Actin was used as loading control.
in Figure 1(a) (Merge panel), the JNK active form p-JNK
was located in presynaptic compartment and colocalizedwith
Synaptophysin. This evidence is also confirmed by Pearson’s
coefficient value, corresponding to 0.54 ± 0.08.
JNK presynaptic localization was further investigated
comparing the presynaptic to the postsynaptic fraction and to
total brain homogenate. JNK and activated form p-JNK were
evaluated by western blotting on total cortical homogenate,
cortical synaptosomal lysate (presynaptic compartment), and
TIF fractionation (postsynaptic compartment; Figure 1(b)).
The P-JNK activated form, as well as the JNK total form, was
detectable in the presynaptic compartment (Figure 1(b)) con-
firming the Super Resolution Microscopy data (Figure 1(a)).
In the postsynaptic TIF fractionation, identified by PSD95
scaffold protein, JNK was present as expected. The purity of
the synaptosomes was confirmed by the low presence of PSD-
95 in the presynaptic fraction, which as described by Evans
[46] is accountable to the nonfunctional PSD structure bound
to active zone. FurthermoreTIF fraction puritywas proved by
the low presence of Synaptophysin in postsynaptic fractions.
3.2. JNK Is Rapidly Activated after Pre-NMDARs Stimula-
tion Both in Young and in Adult Mice. To investigate pre-
NMDAR-mediated JNK activation, we evaluated p-JNK/JNK
ratio by western blotting on cortical synaptosomes purified
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from young (p14) and adult mice after 2󸀠, 5󸀠, and 10󸀠 minutes
of treatment with NMDA (100 𝜇M) and glycine (1 𝜇M).
In young mice synaptosomes (Figure 2(a)), JNK was
significantly activated after 2 minutes of NMDA stimulation
(75% activation increase, ∗𝑝 < 0.05) and persisted after 5
minutes (70% activation increase, ∗𝑝 < 0.05; Figure 2(a)). No
significant alteration in the levels of presynaptic protein was
detected by western blotting (Figures 2(b)–2(e)), suggesting
that, at the considered time-points (2󸀠, 5󸀠, and 10󸀠 minutes),
JNK activation did not determine the activation of protein
degradation processes.
As previously described, pre-NMDARs expression de-
creases during neurodevelopment [43]: to verify if pre-
NMDAR-mediated JNK activation was conserved in adult
mice, synaptosomes were extracted from aged mice. To test
if residual pre-NMDARs expression was enough to trigger
depolarization, calcium currents were measured on synap-
tosomes by pre-ncubation with Fluo4 cell-permeant calcium
sensitive dye. Synaptosomes were stimulated with NMDA
(100 𝜇M) and glycine (1 𝜇M)orKCl 50mMas positive control
(Figure 2(f)). Recording of calcium influx was performed
with a spectrophotometer for 7 minutes, corresponding to
180 fluorescence-reading cycles, with stimulus injection at
45 sec (cycle 20, Figure 2(f) black arrow).This time-point has
been chosen as a compromise to avoid aberrant fluorescence
measurement due to homeostasis loss caused by lack of CO2
and humidity control in the spectrophotometer chamber.
As expected KCl injection led to a rapid and significant
increase of intrasynaptosomal calcium levels lasting over
time. Similarly, NMDA administration led to a comparable
significant increase in fluorescence if compared to controls
injected with vehicle, starting 45 sec (20 cycles) after injection
and remaining stable over time. Unexpectedly we observed a
drop in fluorescence level in vehicle injected synaptosomes
(CTR); however, in line with previous data, NMDA+ Gly
stimulation led to rapid JNKactivation at 2min (50% increase
∗∗∗𝑝 < 0.001), which increases at 5min (60% increase,
∗∗∗𝑝 < 0.001) and persisted at 10min (50% increase, ∗∗𝑝 <
0.01; Figure 2(g)). These data suggested that pre-NMDAR-
JNK axis was conserved during adult life. In fact, pre-
NMDARs retained the ability to trigger excitatory response.
The stimulation with NMDA (100 𝜇M) and glycine (1 𝜇M)
induced JNK activation in both young (p14) and adult
synaptosomes, and the consequent p-JNK/JNK ratio was
comparable. As for young synaptosomes, also in this case,
no significant protein degradation events were observed: no
significant change of presynaptic proteins levels (Syntaxin-1
and Syntaxin-2, Snap25, and Vamp) at the considered time-
points (2󸀠 5󸀠 and 10󸀠) was found (Figures 2(h)–2(k)).
3.3. Investigation of JNK Possible Targets. To get more insight
into JNK modulation of vesicle release, JNK binding domain
(JBD) was searched among presynaptic machinery pro-
teins amino acidic sequences. In recent years, the extensive
characterization of the JBDs in several JNK substrates [5]
allowed identification of a canonical amino acid pattern
for the JNK-substrate interaction. This canonical pattern is
composed of two positively charged and two hydrophobic
residues separated by two spacer regions with different
length: [KR]-X(0,2)-[KR]-X(0,4)-[LI]-X- [LI] [47]. Among the
critical steps involved in neurotransmitter release we decided
to consider vesicle docking and priming steps, since previ-
ously reported data showed that JNK specific inhibition is
not associated to any modification in calcium influx after
NMDAR stimulation [25]. Thus it is unlikely that JNK could
act on modulating this process in the presynaptic compart-
ment. As reported in Figure 3(a), there are two possible
JBDs in Syntaxin-1 and three in Syntaxin-2, respectively. Two
out of three possible JBDs are conserved between Syntaxin-
1 and Syntaxin-2 (Figure 3(a)). In particular, the JBD among
residues 148–155 is fully conserved between the two isoforms
(Figure 3(a)) making this region a very good candidate to
be involved in the interaction with JNK. Analyzing also the
sequence of Snap25, a unique putative JBD has been found
(Figure 3(b)). The presence of putative JBDs pattern in three
presynaptic machinery proteins is a strong indication of
possible physical interaction of those proteins with JNK.
3.4. JNK Interacts with SNAREProteins. Thepresence of JBDs
sequences in three members (Syntaxin-1, Syntaxin-2, and
Snap25) of the SNARE protein family allowed us to predict
the possible three-dimensional (3D) organization of the JNK-
SNARE protein complexes using computational approach,
the protein-protein docking (Figures 3(c)-3(d)). The JBD
sequence, fully conserved in both isoforms of Syntaxin
(residues 148–155), has been mapped on the structure of
Syntaxin-1 [48], which we have chosen as a representative
structure also for Syntaxin-2, because they share a sequence
identity of 64.4% and sequence similarity of 80% (Fig-
ure 3(c)).The unique JBD sequence located between residues
30 and 35 in Snap25 was also mapped on the 3D structure
(Figure 3(d)).
The JBD present on the SNARE proteins and the region
of JNK1 contacting the JIP peptide was used to drive
the docking simulation performed with HADDOCK 2.2
software [49]. The best Syntaxin-1-JNK and Snap25-JNK
complexes were reported in Figures 3(c) and 3(d) with
residues belonging to the JBDs underlined. Both complexes
have a favourable HADDOCK score that is a sum of different
energy contribution terms (i.e., electrostatic energy, Van der
Waals energy, desolvation energy, and restraints violation
energies). In detail, the Syntaxin-1-JNK best complex reports
an HADDOCK score of −24.9 ± 6.2 while the Snap25-JNK1
reports anHADDOCK score of −115.3 ± 0.8, underlining that
the second complex formation could be more favoured. In
both complexes the JBDs are involved in a dense network of
hydrophobic and electrostatic interaction with JNK that are
crucial for the stability of the complexes.
To prove these interactions, SNARE proteins were eval-
uated with western blotting, after immunoprecipitation of
Syntaxin-1, Syntaxin-2, and Snap25 on purified cortical
synaptosomal lysates. JNK was found in the coprecipitate;
in particular the JNK protein band was more detectable
with Syntaxin-2 and Syntaxin-1 and was less intensely visible
with Snap25 (Figures 4(a), 4(b), and 4(c)). To confirm
the interaction of JNK with Syntaxin-1, Syntaxin-2, and
Snap25, the reverse immunoprecipitation on purified cortical
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Figure 2: JNK is activated after pre-NMDARs stimulation in young mice and adult. (a–e) Western blotting and relative quantification of
JNK activation (a), measured as p-JNK/JNK ratio, on p14 mice crude synaptosomes stimulated with NMDA 100 𝜇M and glycine 1 𝜇M for 2,
5, and 10 min. JNK activation significantly increases 2min after treatment (∗𝑝 < 0.05) and persists at 5min (∗𝑝 < 0.05). Western blotting
and relative quantification of presynaptic proteins Syntaxin-1 (b), Syntaxin-2 (c), Snap25 (d), and Vamp (e) extracted from p14 mice crude
synaptosomes stimulated with NMDA 100 𝜇M and glycine 1 𝜇M for 2, 5, and 10min. Protein levels remain unchanged after treatment at the
considered time-points. Actin was used as loading control (20 𝜇g proteins loaded; 𝑁 = 5). One-way ANOVA, Dunnet’s post-hoc test. Data
are showed as mean ± S.E.M. (f) Calcium currents, measured with calcium sensible fluorophore Fluo4, on crude synaptosomes treated with
NMDA 100 𝜇Mand glycine 1𝜇Mor with KCl 50mM. Fluorescence was recorded with a spectrophotometric approach for 7min, with NMDA
+ Gly or KCl injection at 45 sec. After both injections there was a significant increase in calcium levels starting from 45 sec after stimulation
(each experimental group𝑁 = 5). One-way ANOVA, Dunnet’s post hoc test. Data are shown as mean ± S.E.M. (g–k) Western blotting and
relative quantification of JNK activation (g), measured as p-JNK/JNK ratio on adultmice crude synaptosomes stimulatedwithNMDA 100 𝜇M
and glycine 1 𝜇M for 2, 5, and 10min. JNK activation increases 2min after treatment (∗∗∗𝑝 < 0.001) and persists at 5min (∗∗∗𝑝 < 0.01) and
at 10min (∗∗𝑝 < 0.01). Western blotting and relative quantification of presynaptic proteins Syntaxin-1 (h), Syntaxin-2 (i), Snap25 (j), and
Vamp (k) extracted from adult mice crude synaptosomes stimulated with NMDA 100 𝜇M and glycine 1 𝜇M for 2, 5, and 10min. Protein levels
remained unchanged after treatment for all three time-points. Actin was used as loading control (20𝜇g proteins loaded; 𝑁 = 4). One-way
ANOVA, Dunnet’s post hoc test. Data are shown as mean ± S.E.M.
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Figure 3: JBD is crucial for SNARE interaction with JNK. (a) Sequence alignment between Syntaxin-1 and Syntaxin-2. The JBDs are
underlined in red. (b) Sequence of Snap25 with the JBD underlined in red. On top of panels (a) and (b) the canonical JBD pattern is also
reported. (c) Best JNK-Syntaxin complex resulting from the docking predictions. JNK is shown in light blue and Syntaxin in gold.The lateral
chains of the residues belonging to the JBD are shown in red. (d) Best complex of the JNK-Snap25 docking results. Also in this case JNK is
depicted in light blue while Snap25 is shown in light brown. The lateral chains of the residues of the JBD in Snap25 are reported in red.
synaptosomal lysates was performed. According to data
previously found mostly Syntaxin-2 and Syntaxin-1 were
traceable in JNK’s coprecipitate (Figure 4(d)). However, a
precise quantification is not possible due to the different
efficiency of the antibodies used.
3.5. SNARE Proteins Interact Both with JNK2 and with JNK3.
To investigate if a specific JNK isoform was involved in the
interaction with SNARE protein complex, single JNK iso-
form precipitation was performed on cortical synaptosomal
lysates. After precipitation of JNK3 [7, 50], an isoform known
to be more sensitive to NMDA stimulation, and of JNK2, an
isoform known to be important for neural plasticity, SNARE
protein expression was evaluated by western blotting in the
coprecipitate. Presence of both Syntaxin-2 and Snap25 was
traceable in JNK2 coprecipitate (Figure 5, left panel); similarly
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Figure 4: JNKpreferentially interacts with Syntaxin-1, Syntaxin-2, and Snap25. (a–c)Western blotting after immunoprecipitation of Syntaxin-
1 (a), Syntaxin-2 (b), and Snap25 (c) on purified synaptosomes lysates extracted from adult mice cortex. JNK is detectable in Syntaxin-1 and
Syntaxin-2 precipitate, while immunoreactive signal is weak in Snap25 precipitate. (d) Both Syntaxin-1 and Syntaxin-2, as well as Snap25, were
detectable in JNK precipitate. 500𝜇g of total lysates has been subjected to immunoprecipitation, while 20𝜇g was loaded as control.𝑁 = 4.
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Figure 5: Both JNK2 and JNK3 interact with Syntaxin-2 and Snap25. Western blotting after immunoprecipitation of JNK2 (left) and JNK3
(right) on purified synaptosomes lysates extracted from adult mice cortex. Syntaxin-2 and Snap25 were detectable both in JNK2 and in JNK3
precipitate. 500 𝜇g of total lysates has been subjected to immunoprecipitation, while 20𝜇g was loaded as control (each experimental group
𝑁 = 3).
both SNAREs were present in JNK3 coprecipitate (Figure 5,
right panel). These results indicated that both JNK isoforms,
JNK3 and JNK2, interact with Syntaxin and Snap25, without
having a preferential interaction with a specific isoform.
3.6. JNK Inhibition Reduces the Frequency but Not the Ampli-
tude of mEPSCs in Cortical Slices. To determine the site
of synaptic modifications induced by JNK, the miniature
excitatory postsynaptic currents (mEPSCs) were examined in
the presence of JNK inhibitor, D-JNKI1. Miniature synaptic
events are due to the spontaneous release of glutamate
vesicles, which in turn activates postsynaptic glutamate
receptors. According to the quantal hypothesis, changes in
the amplitudes of mEPSCs reflect a change in postsynaptic
responsiveness, whereas presynapticmechanisms result in no
change in the amplitude of the mEPSCs but may cause a
change in the frequency of mEPSCs recorded in the post-
synaptic cell [51, 52]. The mEPSCs were, therefore, recorded
in cortical slices, pretreated for 1 hr with D-JNKI1 (2𝜇M),
in the presence of TTX (1 𝜇M) to prevent action-potential
firing, and bicuculline (20 𝜇M) to block GABAergic currents.
As shown in Figure 6(a) (sample traces of mEPSCs) and
in Figures 6(b)-6(c) (quantification of mEPSCs frequency
and amplitude), D-JNKI1 induced a significant decrease in
the frequency of mEPSCs if compared to control conditions
(∗𝑝 < 0.05, 𝑁 = 8) but had no statistically significant effect
on mEPSCs amplitude. These results support the hypothesis
that JNK can act presynaptically to regulate transmitter
release.
3.7. JNK Inhibition Reduces SNARE Complex Formation after
NMDA Stimulation. Having demonstrated JNK interaction
with Syntaxin-1/Syntaxin-2 as well as with Snap25 and that
the specific inhibition of JNK,withD-JNKI1, reduced sponta-
neous release in an in vitro slice preparation.We here studied
the effect of D-JNKI1 on JNK-SNARE complex formation
in control condition and after NMDA stimulation. The
SNARE complexes (Syntaxin + Snap25 +Vamp) are detergent
resistant structures and can be visualized by western blotting
on unboiled samples [53]. Anti-Syntaxin-1 antibody was
used to visualize SNARE complex at approximately 75–100
KDa and used for densitometric quantification. Higher MW
signals, ascribable to more structured complexes, enriched
with other release-machinery factors, were detected too.
The synaptosomes were treated with D-JNKI1 (2 𝜇M) for 25
minutes. Inhibition of JNK did not affect SNARE complex
assembly in control condition. When synaptosomes were
stimulated by NMDA (100 𝜇M NMDA plus 1𝜇M glycine),
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Figure 6: D-JNKI1 treatment reduced the frequency of mEPSCs in
mice cortical slices. (a) Representative traces of mEPSCs recorded
from cortical slices under control condition or after incubation
with D-JNKI1n for 1 hr. (b-c) Bar graph (mean ± SEM) showing
the mEPSC frequency (b) and amplitude (c) obtained in the first
5min of recordings from control (𝑁 = 8) and D-JNKI1-treated
(𝑁 = 8) cortical neurons. CTR versus D-JNKI1 treatment: ∗𝑝 < 0.05
Student’s t-test, n =8. Data are shown as mean +/− SEM.
there was a significant 50% increase of complex formation
(∗𝑝 < 0.05) after 7 minutes of treatment, due to the increased
vesicle release triggered by the pre-NMDARs activation
(Figure 7(a)). When synaptosomes were firstly pretreated
with D-JNKI1 (2𝜇M) for 25 minutes and then stimulated
with NMDA, SNARE complex assembly was significantly
prevented (#𝑝 < 0.05) and complex levels were restored to
nonstimulated control levels (see Figure 7(a)). These results
showed that JNK inhibition prevented SNARE proteins com-
plexation, according to electrophysiology data. Finally, the
levels of SNARE complex proteins were evaluated in boiled
samples for all the conditions, control synaptosomes with
and without D-JNKI1 as well as synaptosomes stimulated by
NMDA with and without D-JNKI1. No change in protein
levels was observed under these conditions (Figures 7(b)–
7(d)). However we were not able to detect any reduction
of noncomplexed Syntaxin-1 in unboiled NMDA treated
samples, even though a significant reduction could have been
expected due to Syntaxin-1 assembly in SNARE complex.This
might probably be due to the huge enrichment of Syntaxin-
1 in synaptosomal fraction, whose alterations in the protein
levels cannot be conclusively evaluated by western blotting.
4. Discussion
JNK kinase plays an important role in regulating several
functions in the central nervous system and in synaptic
plasticity processes [54, 55]. In particular, a specific JNK pool
in the postsynaptic site is able to modulate synaptic strength
regulating both AMPA and NMDA glutamate receptors
localization in the postsynaptic density region (PSD). This
feature is partially due to JNK interaction with PSD scaffold
protein PSD95 [56], but also by its direct interaction with
NR2A/B [57, 58]. Importantly, in pathological conditions,
such as Alzheimer’s disease (AD) synaptopathy, JNK induces
a massive removal of glutamate receptors (AMPA and
NMDA) from PSD region, leading to LTP impairment, LTD
increase [18, 31], anddendritic spines loss [17, 31]. JNK’s role in
the regulation of glutamatergic synapse dysfunction and dys-
morphogenesis is intriguing and not completely established.
The JNK postsynaptic function is well recognized. In fact,
JNK is rapidly activated after glutamate receptors stimulation
[59], and in addition plays a key role in NMDA-induced
neuronal-death (excitotoxicity; see [10, 60, 61]). Despite the
great amount of data supporting JNK function after NMDA
activation, nothing is known by now about JNK involvement
in presynaptic NMDARs (pre-NMDARs) downstream path-
way. The pre-NMDARs are present at the presynaptic site
in the more plastic brain regions in adult, such as cortex
and hippocampus [62], where they control neurotransmitter
release [63, 64].The activation of JNK signalling after NMDA
stimulation at the presynaptic site is not proven yet, and
only few studies have proposed a presynaptic role for JNK
[65]. Many findings in literature show that synaptosomes
preparation is a valid tool to value presynaptic compartment
and related receptors, as previously described. By studying
pre-NMDARs stimulation in synaptosomes, we showed for
the first time JNK activation in the presynaptic site. Thanks
to both microscopic and biochemical approaches, in fact,
we detected JNK and its activated form, p-JNK, in cortical
presynaptic terminals. Notably its levels in presynaptic site
seem comparable to those of postsynaptic site, previously
characterized ([17], see Figures 1 and 2).Weproved and exam-
ined JNK activation after pre-NMDA receptors stimulation
directly at pre-synaptic site (synaptosomes) in both young
and adult cortex preparations. Interestingly, JNK activation
rateswere comparable for young and adult preparations, indi-
cating that pre-NMDARs stimulation induced JNKactivation
in the presynaptic site at both ages. In addition, this process
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Figure 7: JNK inhibition reduces SNARE complex formation. (a) Western blotting and relative quantification of SNARE complex levels
(anti-Syntaxin-1 immunoreactive bands from approximately 75 to 100KDa) in 20 𝜇g of crude synaptosomes stimulated with NMDA
100 𝜇m and glycine 1 𝜇m for 7min in presence or absence of D-JNKI1 (2𝜇m), added to synaptosomes 25min before stimulation. After
NMDA/Gly exposure there was a significant increase in SNARE complexes formation (∗𝑝 < 0.05), which is totally prevented by D-JNKI1
preadministration (#𝑝 < 0.05). SNARE complexes are normalized on actin, 𝑁 = 6. Data are shown as mean ± SEM, Two-way ANOVA,
Tukey's post hoc test. (b–d)Western blotting and relative quantification of Syntaxin-1, Syntaxin-2, and Snap25 in 20 𝜇g of crude synaptosomes
stimulated with NMDA 100 𝜇m and glycine 1 𝜇m for 7min in presence or absence of D-JNKI1 (2𝜇m), added to synaptosomes 25min before
stimulation. There was no significant variation of protein levels after NMDA/Gly exposure as well as after D-JNKI1 administration alone or
in combination with NMDA/Gly. Proteins are normalized on actin,𝑁 = 6. Two-way ANOVA, Tukey’s post hoc test. Data are shown as mean
± SEM.
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is conserved after neurodevelopment although pre-NMDARs
expression is widely decreased and persisted only in cortex
and hippocampus in adult [62]. No alteration of presynaptic
proteins levels was observed in synaptosomes, suggesting that
JNK is not involved in protein degradation, as what occurs in
the postsynaptic compartment [17, 18, 30].
Literature evidences suggest that presynaptic kinases reg-
ulate neurotransmitter release, mainly affecting three steps:
stored vesicle mobilization [66], axonal ending depolariza-
tion due to calcium influx [67], and presynaptic vesicles
fusion [68]. In this context the role of JNK in regulating
presynaptic tasks is poorly understood: there are only few
data reporting vesicle mobilization as an important step in
spontaneous release [69], while JNK inhibition had already
been proven not to change calcium intracellular levels [25]
suggesting that it is unlikely that the kinase could mod-
ulate calcium channels or NMDA receptors permeability.
Thus thanks to our modelling design finding, we examined
whether JNK acts as a physiological effector of SNARE com-
plex formation regulating vesicle release. The biochemical
data confirmed the prediction of the computational analysis,
suggesting the interaction of JNK with Syntaxin-1, Syntaxin-
2, and Snap25 as well as with the SNARE complex formation.
We have demonstrated that Syntaxin-1 and Syntaxin-2 share
around 64% of sequence identity and there is only one JBD
motif fully conserved in both isoforms, while we found only
one complete JBD motif into the Snap25 sequence. Once we
got these data from the sequence alignment, we were able to
map the JBD on the Syntaxin-1/Syntaxin-2 and Snap25 three-
dimensional (3D) structures in order to perform the docking
simulation. The results of the docking simulations can show
the possible conformations of the Syntaxin-1/Syntaxin-2-JNK
and Snap25-JNK complexes. However, the electrophysiolog-
ical and biochemical experiments proved the rationale of the
docking hypothesis.
To get more insight into JNK presynaptic function, we
examined the effects of the specific JNK inhibitor D-JNKI1
on mEPSCs recorded from cortical slices. By preventing JNK
action, the frequency, but not the amplitude, of mEPSCs
was strongly reduced (50%) thus confirming a modulation
of presynaptic release probability by JNK. These results
combined with the biochemical findings suggest that the
interaction of JNK with Syntaxin-1 and Syntaxin-2 as well as
Snap25 at the presynaptic level could represent an important
mechanism for regulating vesicle release.
Whether the JNK binding to Snap25 is direct or mediated
by Syntaxin is difficult to establish since there are many
interactions among the T-SNARE proteins that form the
complex, including Syntaxin and Snap25 which, in resting
conditions, are partially assembled in a primed structure [70–
72]. For this reason, we evaluated NMDA-mediated SNARE
complex assembly in presence of specific D-JNKI1 inhibitor.
As expected, JNK inhibition reduces SNAREs complexation,
indicating JNK as a modulator of vesicle docking-priming,
via Syntaxin/Snap25 direct interactions and probably phos-
phorylation. Such effect may result in a fine regulation of
neurotransmitter release by JNK signalling pathway.
We then tried to clarify which JNK isoforms are more
prone to interact with Syntaxin-1/ Syntaxin-2 and Snap25.
The brain specific JNK3 isoform,majorly related toNMDARs
activation [7, 50], is the most intriguing form, but unfor-
tunately the antibodies are not able to discriminate well
among JNK isoforms. Immunoprecipitation assay suggests a
functional overlapping between the two isoforms, JNK2 and
JNK3. Further studies are needed to clarify this issue. These
findings all together unravel a new and important role of JNK
in the presynaptic site.
5. Conclusions
The JNK stress-signalling pathway is indicated as a key
player in developmental and neurodegenerative patholo-
gies. Its implication in excitotoxicity and synaptic dysfunc-
tion/dysmorphogenesis makes its importance clear. JNK
represents a therapeutic target against neurodegenerative
processes, but much information is missing to manipulate
its action in order to reduce unwanted adverse effects. In
this work we demonstrated for the first time that JNK
leads to neurotransmitter release facilitation, due to a direct
interaction with SNARE proteins. Thus an important new
role of JNK in controlling synaptic plasticity emerges from
this study, adding another part of the story to better clarify
JNK function in synapse modulation.
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